An Institute of Medicine report recommends that FDA improve its processes for monitoring the safety of prescription drugs after they are approved. FDA currently uses IT initiatives like the Sentinel system to conduct post-approval monitoring of prescription drug safety. According to IOM, improvements in health IT and analytics could help advance such monitoring efforts. Reuters et al.